Eurobio Scientific Société anonyme (EPA:ALERS)
23.00
0.00 (0.00%)
Apr 29, 2026, 10:44 AM CET
EPA:ALERS Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 4 | 4.84 | 24.94 | 60.54 | Upgrade
|
| Depreciation & Amortization | - | 9.51 | 13.15 | 9.63 | 7.87 | Upgrade
|
| Other Amortization | - | 4.55 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.07 | 0.06 | -1.77 | - | Upgrade
|
| Other Operating Activities | - | 2.88 | 0.39 | 1.43 | 1.17 | Upgrade
|
| Change in Accounts Receivable | - | -2.84 | 12.9 | 20.84 | 2.05 | Upgrade
|
| Change in Inventory | - | -3.84 | 2.04 | 0.24 | -3.3 | Upgrade
|
| Change in Unearned Revenue | - | -0.08 | -0.24 | 0.28 | -0.03 | Upgrade
|
| Change in Other Net Operating Assets | - | 2.46 | -6.35 | -12.52 | -2.39 | Upgrade
|
| Operating Cash Flow | - | 16.7 | 26.77 | 43.07 | 65.92 | Upgrade
|
| Operating Cash Flow Growth | - | -37.60% | -37.86% | -34.66% | 20.00% | Upgrade
|
| Capital Expenditures | - | -3.26 | -4.05 | -2.83 | -1.85 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.17 | 1.9 | 2.52 | 0.1 | Upgrade
|
| Cash Acquisitions | - | -10.12 | -4.5 | -132.16 | - | Upgrade
|
| Investment in Securities | - | 2.47 | 6.34 | -9.28 | -3.72 | Upgrade
|
| Other Investing Activities | - | -0 | - | - | 0 | Upgrade
|
| Investing Cash Flow | - | -10.74 | -0.32 | -141.76 | -5.47 | Upgrade
|
| Short-Term Debt Issued | - | 23.45 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 105 | - | Upgrade
|
| Total Debt Issued | - | 23.45 | - | 105 | - | Upgrade
|
| Long-Term Debt Repaid | - | -92.72 | -18.2 | -9.25 | -15.96 | Upgrade
|
| Net Debt Issued (Repaid) | - | -69.27 | -18.2 | 95.75 | -15.96 | Upgrade
|
| Repurchase of Common Stock | - | -0.15 | -2.79 | -12.24 | -6.91 | Upgrade
|
| Other Financing Activities | - | -2.67 | -2.51 | -1.21 | -0.88 | Upgrade
|
| Financing Cash Flow | - | -72.09 | -23.5 | 82.31 | -23.76 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.16 | 0.15 | -0.08 | 0.14 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | - | -65.96 | 3.09 | -16.45 | 36.83 | Upgrade
|
| Free Cash Flow | - | 13.45 | 22.71 | 40.24 | 64.07 | Upgrade
|
| Free Cash Flow Growth | - | -40.80% | -43.55% | -37.19% | 21.73% | Upgrade
|
| Free Cash Flow Margin | - | 8.68% | 17.39% | 26.32% | 34.57% | Upgrade
|
| Free Cash Flow Per Share | - | 1.31 | 2.02 | 3.54 | 5.89 | Upgrade
|
| Cash Interest Paid | - | 2.66 | 2.47 | 1.23 | 0.46 | Upgrade
|
| Levered Free Cash Flow | - | 12.59 | 16.39 | 44.88 | 46.34 | Upgrade
|
| Unlevered Free Cash Flow | - | 15.17 | 19.11 | 45.67 | 46.6 | Upgrade
|
| Change in Working Capital | - | -4.3 | 8.35 | 8.84 | -3.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.